BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 16316970)

  • 21. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
    Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat.
    Ding G; Jiang Q; Zhang L; Zhang Z; Knight RA; Soltanian-Zadeh H; Lu M; Ewing JR; Li Q; Whitton PA; Chopp M
    J Neurol Sci; 2004 Aug; 223(2):135-43. PubMed ID: 15337614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
    Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
    Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.
    Zhang L; Zhang ZG; Liu XS; Hozeska-Solgot A; Chopp M
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2470-5. PubMed ID: 17717296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y; Li Q; Yang T; Hussain M; Shuaib A
    J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
    Zhang L; Zhang Z; Zhang RL; Cui Y; LaPointe MC; Silver B; Chopp M
    Brain Res; 2006 Nov; 1118(1):192-8. PubMed ID: 16959227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
    Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
    Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Knight RA; Ewing JR; Ding G; Lu M; Arniego P; Zhang L; Hu J; Li Q; Chopp M
    J Cereb Blood Flow Metab; 2002 May; 22(5):559-68. PubMed ID: 11973428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.
    Furuichi Y; Maeda M; Matsuoka N; Mutoh S; Yanagihara T
    Exp Neurol; 2007 Mar; 204(1):138-46. PubMed ID: 17169359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of alteplase, a thrombolytic agent, in a rat photothrombotic middle cerebral artery occlusion model.
    Umemura K; Higo K; Sakata T; Yuki S; Iwata K; Yamaguchi K
    Pathophysiol Haemost Thromb; 2008; 36(5):245-50. PubMed ID: 19996634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats.
    Wang CX; Ding X; Noor R; Pegg C; He C; Shuaib A
    J Cereb Blood Flow Metab; 2009 Oct; 29(10):1683-94. PubMed ID: 19553906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
    Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
    Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
    Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
    Yemisci M; Ay H; Kocaefe C; Qui J; Topalkara K; Ozgüç M; Kirazli S; Ozcebe O; Moskowitz MA; Dalkara T
    Cerebrovasc Dis; 2008; 26(2):190-8. PubMed ID: 18628618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
    Romanos E; Planas AM; Amaro S; Chamorro A
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probability of metabolic tissue recovery after thrombolytic treatment of experimental stroke: a magnetic resonance spectroscopic imaging study in rat brain.
    Franke C; Brinker G; Pillekamp F; Hoehn M
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):583-91. PubMed ID: 10724122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.